# Luma Bio-It Management

Luma Bio-It Management is a Private Equity based in New York, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** New York, United States
- **Region:** North America
- **Address:** New York, United States
- **Founded:** 2018
- **Assets under management:** Undisclosed

## Regulatory record

- **CRD number:** 293748
- **SEC file number:** 802-112793
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/293748

## About

Luma Bio-It Management, LLC is an exempt reporting adviser in New York, NY. The firm advises on investment strategies. It is based in New York.

## Sectors

- Digital Health
- Enterprise Software

## Questions

### What does Luma Bio-It Management invest in?

Luma targets control and growth-equity investments in enterprise software companies that serve the life sciences and healthcare sectors. The firm focuses on platforms handling clinical trials, regulatory submissions, and compliance workflows for biopharma and medical-device customers. This niche requires software built to FDA, EMA, and HIPAA standards — a barrier that limits competitive encroachment.

### What is Luma Bio-It Management's geographic focus?

Primary investment activity concentrates on North America and Western Europe. These regions share mature regulatory frameworks — FDA in the United States, EMA in the European Union — that create durable demand for the specialized software platforms in which Luma invests.

### Does Luma Bio-It Management invest in healthcare services or therapeutics?

No. The firm invests exclusively in enterprise software companies that serve healthcare and life sciences end-markets. It does not invest in provider groups, payors, pharmaceutical R&D, or medical devices. The differentiation from traditional healthcare private equity lies in this software-only mandate.

### What separates Luma from generalist healthcare or software PE funds?

Most healthcare PE funds lack deep software-operating expertise; most software funds lack regulatory-compliance fluency. Luma requires both. The firm recruits operating partners who have built and sold FDA-regulated software platforms, and underwriting embeds regulatory-outcome modeling into return projections.

## Related profiles

- [Lufeng Capital](https://altss.com/profile/lufeng-capital)
- [Lundgreen's Capital](https://altss.com/profile/lundgreens-capital)

---

Last updated: 2026-08-14T12:30:00.000Z

Canonical page: https://altss.com/profile/luma-bio-it-management-llc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology